| Literature DB >> 36152173 |
Mauro Maccarrone1,2.
Abstract
Endocannabinoids (eCBs) are endogenous lipids able to bind to cannabinoid receptors, the primary molecular targets of the cannabis (Cannabis sativa) active principle Δ9-tetrahydrocannabinol. During the last 20 years, several N-acylethanolamines and acylesters have been shown to act as eCBs, and a complex array of receptors, metabolic enzymes, and transporters (that altogether form the so-called "eCB system") has been shown to finely tune their manifold biological activities. It appears now urgent to develop methods and protocols that allow to assay in a specific and quantitative manner the distinct components of the eCB system and that can properly localize them within the cell. A brief overview of eCBs and of the proteins that bind, transport, and metabolize these lipids is presented here, in orderto put in a better perspective, the relevance of methodologies that help to disclose molecular details of eCB signaling in health and disease. Proper methodological approaches form also the basis for a more rationale and effective drug design and therapeutic strategy to combat human disorders.Entities:
Keywords: 2-Arachidonoylglycerol; Anandamide; Enzyme assays; Immunochemical assays; Intracellular trafficking; Localization; Metabolic routes; Oxidative pathways; Receptor binding assays; Signal transduction
Mesh:
Substances:
Year: 2023 PMID: 36152173 DOI: 10.1007/978-1-0716-2728-0_1
Source DB: PubMed Journal: Methods Mol Biol ISSN: 1064-3745